Envoy Medical (COCH) Liabilities and Shareholders Equity (2020 - 2026)

Envoy Medical has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $29.8 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $29.8 million, up 187.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.5 million (up 48.36% YoY), and the FY2025 annual result was $8.6 million, down 25.83% from the prior year.
• Liabilities and Shareholders Equity came in at $29.8 million for Q1 2026 at Envoy Medical, up from $8.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $427.8 million in Q3 2022 to a low of $2.6 million in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $10.4 million (2025), against an average of $88.7 million.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 99.4% in 2022 and soared 223.59% in 2023, its largest moves.
• Envoy Medical's Liabilities and Shareholders Equity stood at $2.6 million in 2022, then jumped by 223.59% to $8.3 million in 2023, then soared by 39.5% to $11.5 million in 2024, then retreated by 25.83% to $8.6 million in 2025, then soared by 248.47% to $29.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $29.8 million (Q1 2026), $8.6 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.